Viagra for the Ladies?
Did you know that there's a condition called "hypoactive sexual desire disorder," from which many women suffer? Well, there is, or at least a bunch of scientists have decided there is, and sadly, about 10 percent of premenopausal women grapple with it. Luckily, if unsurprisingly, there might be a pill in the works for just this issue.
Did you know that there’s a condition called “hypoactive sexual desire disorder,” from which many women suffer? Well, there is, or at least a bunch of scientists have decided there is, and sadly, about 10 percent of premenopausal women grapple with it. Luckily, if unsurprisingly, there might be a pill in the works for just this issue. –KA
Wait, before you go…Nizagara-online.net via Gawker:
“We have to give women some type of option,’’ said Beverly Whipple, a professor emeritus at Rutgers University and an expert on women’s sexual health. “I’m hoping this will help the women who need it.’’
One expert, Andrew Goldstein who runs the Sexual Wellness Center in Annapolis, Md., described a “huge’’ unmet need for a medical treatment.
Women who took the medicine, known as flibanserin, reported 22 percent more “satisfying sexual events” than those given a placebo in two clinical tests of 1,378 patients, according to abstracts released today at the European Society for Sexual Medicine annual meeting in Lyon, France.
If you're reading this, you probably already know that non-profit, independent journalism is under threat worldwide. Independent news sites are overshadowed by larger heavily funded mainstream media that inundate us with hype and noise that barely scratch the surface. We believe that our readers deserve to know the full story. Truthdig writers bravely dig beneath the headlines to give you thought-provoking, investigative reporting and analysis that tells you what’s really happening and who’s rolling up their sleeves to do something about it.
Like you, we believe a well-informed public that doesn’t have blind faith in the status quo can help change the world. Your contribution of as little as $5 monthly or $35 annually will make you a groundbreaking member and lays the foundation of our work.
Support Truthdig
Book Excerpt
Seventy-five years ago in Chicago, a conservative project was hatched to cure classical economics of its aversion to patents and monopolies. The drug companies were its first and biggest beneficiaries.
Business & Economy
The pharmaceutical giant refuses to make its vaccine technology available to all.
The presidential candidate travels with a caravan of type 1 diabetes patients seeking affordable insulin in America's northern neighbor.
The president is now focusing his drive to curb drug costs on congressional efforts.
Lawmakers are trying to set aside their differences on Obamacare and reach agreement on a more immediate health care issue.
There are two leading risk factors for becoming addicted to opioids, and potentially dying of an overdose.
There are currently no responses to this article.
Be the first to respond.